Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 7/7/10 → 8/31/17 |
Funding
- PRA Health Sciences (AC220-002 // AC220-002)
- Ambit Biosciences Corporation (AC220-002 // AC220-002)
PROT# AC220-002: Phase 2 Open-Label, AC220 Monotherapy Efficacy (ACE) Study in Patients with Acute Myeloid Leukemia (AML) with FLT3-ITD Activating Mutations
- Altman, Jessica K (PD/PI)
Project: Research project